Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSMA-PET Imaging in Prostate Cancer with High Decipher Scores
NCT03495427Phase 3Recruiting
- Sponsor
- Moffitt Cancer Center
- Start
- Dec 2019
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Moffitt Cancer Center. Started Dec 2019; status: recruiting.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03495427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03495427.